Express Scripts to Cover AbbVie Hepatitis C Drug, Drops Gilead Treatment
December 22, 2014 at 10:44 AM EST
The nation's largest pharmacy benefit manager has lined up a cheaper price from AbbVie on its newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences treatments, Express Scripts said on Monday.
